Clicky

Tuesday, November 17, 2026

Deals

Mergers, asset sales, and major contracts

Bryan J. Young acquires 3,500 stock options at Sherwin-Williams

Bryan J. Young, Sherwin-Williams SVP, acquires 3,500 stock options, reflecting ongoing trends in corporate compensation within the retail-building materials industry.

Agree Joey Acquires 1,150 Shares in SEC Filing Update

Agree Joey, President and CEO of Agree Realty Corp, acquires 1,150 shares, signaling confidence in the company's direction amid industry changes.

Timothy E. Wood Reports Stock Transactions for USANA

Timothy E. Wood has reported new stock transactions involving USANA Health Sciences, reflecting his ongoing commitment to the company.

Harris Parker Acquires 1,785 Shares of Salesforce Stock

Harris Parker reported a transaction involving 1,785 shares of Salesforce common stock, signaling continued confidence in the company's future.

Nippon Life Insurance Co. Acquires 193,357 Shares in Corebridge

Nippon Life Insurance Co. has purchased over 193,000 shares of Corebridge Financial, signaling confidence in the company's future in the life insurance sector.

Ann McDaniel acquires 29 shares in Match Group via dividend

Ann McDaniel has acquired 29 shares of Match Group through dividend equivalents, increasing her total shares to 64. This reflects her commitment to the company.

Fong Morgan Reports Stock Transactions Under Trading Plan

Fong Morgan, Chief Legal Officer of Maplebear Inc., discloses stock transactions under a trading plan, impacting the business services sector.

Young Wendy B. Acquires 3,789 Shares in Rapport Therapeutics

Young Wendy B. increases her stake in Rapport Therapeutics by acquiring 3,789 shares, signaling confidence in the pharmaceutical sector.

Jaye James R acquires shares through stock options at Sherwin Williams

Jaye James R reports acquisition of 2,335 shares via stock options at Sherwin Williams, emphasizing executive incentives in the retail-building materials sector.

Cavens Darrell acquires shares in Match Group, Inc.

Cavens Darrell's recent share acquisition in Match Group, Inc. signals ongoing commitment and engagement with the company.

Immunovant CTO Sells Shares to Cover Tax Obligations

Immunovant's CTO, Jay Stout, sells shares to cover tax obligations from vested stock, reflecting ongoing equity management in the biological products sector.

Firy Inc. CFO Reports Stock Transactions in SEC Filing

Firy Inc.'s Chief Accounting Officer, Valli Todd, reports stock transactions in a recent SEC filing, indicating ongoing equity management.

Zeta Global's Ravella Satish Reports Stock Transactions

Ravella Satish, Chief Accounting Officer at Zeta Global, reports stock transactions including acquisitions and dispositions of shares.

Rapport Therapeutics director acquires 3,680 shares of stock

Rapport Therapeutics, Inc. director Paul M. Silva acquires 3,680 shares, signaling confidence in the company's growth and direction.

Rapport Therapeutics director acquires over 9,000 shares

John M. Maraganore, a director at Rapport Therapeutics, acquires over 9,000 shares, signaling confidence in the company’s future.

Campbell Kotzman Kelly Reports Dividend Equivalents Transaction

Campbell Kotzman Kelly has disclosed a transaction involving dividend equivalents, impacting their stake in Match Group, Inc.

Rapport Therapeutics director acquires 35,714 shares

Rapport Therapeutics, Inc. reports director Paul Steven M's acquisition of 35,714 shares, signaling confidence in the company's future.

Lang James P. acquires shares via stock options at Sherwin-Williams

Lang James P. reports acquisition of 2,335 shares of Sherwin-Williams through stock options, reflecting the company's executive compensation strategy.

Surrozen director Tim Kutzkey acquires over 1.5 million shares

Tim Kutzkey of Surrozen, Inc. acquired over 1.5 million shares, signaling strong investment interest in the biological products sector.

Column Group Opportunity III GP, LP Reports Stock Transactions

Column Group Opportunity III GP, LP details significant stock transactions in Surrozen, Inc., reflecting ongoing investment in the biotech sector.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →